John S Runge

5PUBLICATIONS
48CO-AUTHORS
Epigenetics (incl. genome methylation and epigenomics)Haematological tumoursPharmacogenomicsCancer therapy (excl. chemotherapy and radiation therapy)Autoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Mar 11, 2025
Selective Enhancer Dependencies in MYC-Intact and MYC-Rearranged Germinal Center B-cell Diffuse Large B-cell Lymphoma.

Ashwin R Iyer, Aishwarya Gurumurthy, Shih-Chun A Chu

|Nov 04, 2022
GATA-3 is a proto-oncogene in T-cell lymphoproliferative neoplasms.

Xiangrong Geng, Chenguang Wang, Xin Gao

|May 03, 2022
Pigmented Purpuric Dermatosis of the Hand: Clinicopathologic Analysis of Six Cases With Review of the Literature.

John S Runge, Mio Nakamura, Annette Nichole Sullivan

|Feb 02, 2022
The physical exam's role in determining dose-limiting toxicity prior to immunochemotherapy administration in lymphoma.

John S Runge, Anna B Brown, Tycel J Phillips

|Oct 26, 2021
Patch/plaque mycosis-fungoides-like presentations of DUSP22-translocated T-cell lymphomas.

John S Runge, Madison L Novice, Naomi Briones

Pageof 1